MONTREAL _ Valeant Pharmaceuticals will pay down some of its debt after agreeing to sell off parts of the company for US$2.1 billion in two separate transactions. The Laval-Que.-based pharmaceutical company said Tuesday it will sell three skincare brands _ CeraVe, AcneFree and AMBI _ to Paris-based L’Oreal for US$1.3 billion in cash.